NPI: 1760427157 · VENICE, FL 34285 · General Acute Care Hospital · NPI assigned 06/18/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTRO/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 06/18/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,134 | $117K |
| 2019 | 27,245 | $367K |
| 2020 | 19,012 | $237K |
| 2021 | 24,774 | $334K |
| 2022 | 9,222 | $150K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,955 | 3,236 | $146K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,809 | 1,409 | $128K |
| 36415 | Collection of venous blood by venipuncture | 6,625 | 4,164 | $113K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 4,002 | 3,003 | $113K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,196 | 1,001 | $72K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,679 | 1,238 | $61K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,769 | 1,245 | $58K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 852 | 691 | $56K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 843 | 739 | $50K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,005 | 1,531 | $50K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,326 | 259 | $46K |
| 80048 | Basic metabolic panel (calcium, ionized) | 6,425 | 4,041 | $38K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,094 | 854 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7,337 | 4,816 | $18K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 745 | 414 | $16K |
| 87077 | 1,212 | 913 | $13K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,146 | 1,252 | $12K |
| 84484 | 2,275 | 1,246 | $12K | |
| 87070 | 851 | 665 | $11K | |
| G0378 | Hospital observation service, per hour | 1,066 | 598 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,548 | 2,534 | $8K |
| 71046 | Radiologic examination, chest; 2 views | 598 | 506 | $8K |
| 71045 | Radiologic examination, chest; single view | 2,392 | 1,785 | $8K |
| 80076 | 1,406 | 1,062 | $8K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,422 | 1,102 | $7K |
| 86885 | 130 | 84 | $7K | |
| 87400 | 295 | 267 | $7K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 923 | 728 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 245 | 138 | $6K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,028 | 798 | $6K |
| 82962 | 1,136 | 474 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,084 | 1,655 | $5K |
| 81001 | 3,160 | 2,492 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,241 | 1,003 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 272 | 203 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,089 | 1,550 | $4K |
| J2704 | Injection, propofol, 10 mg | 1,094 | 843 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 508 | 373 | $3K |
| 85610 | 915 | 611 | $3K | |
| 80053 | Comprehensive metabolic panel | 1,090 | 852 | $3K |
| 83735 | 2,201 | 1,399 | $2K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 122 | 115 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 121 | 79 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 403 | 303 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,696 | 1,987 | $2K |
| 84703 | 269 | 231 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 530 | 421 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,269 | 841 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | 376 | 300 | $2K |
| 97161 | 58 | 42 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 197 | 51 | $2K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 76 | 12 | $1K |
| 87186 | 792 | 595 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 405 | 302 | $1K |
| 72125 | Computed tomography, cervical spine; without contrast material | 370 | 261 | $1K |
| 80061 | Lipid panel | 108 | 91 | $1K |
| 85730 | 210 | 139 | $1K | |
| 86900 | 156 | 108 | $776.65 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 16 | 12 | $771.22 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 20 | 14 | $720.67 |
| 87205 | 509 | 371 | $649.95 | |
| 83605 | 47 | 36 | $641.37 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 46 | 37 | $634.59 |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,805 | 1,313 | $578.32 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 58 | 49 | $576.27 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 104 | 92 | $571.71 |
| J0690 | Injection, cefazolin sodium, 500 mg | 344 | 248 | $565.19 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 40 | 36 | $524.75 |
| 83690 | 1,175 | 933 | $484.87 | |
| 91301 | 87 | 75 | $443.72 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 155 | 52 | $438.66 |
| 82330 | 541 | 436 | $349.58 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 14 | 12 | $327.03 |
| 82550 | 161 | 79 | $286.15 | |
| 87486 | 23 | 20 | $174.89 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 48 | 36 | $169.86 |
| 87430 | 127 | 115 | $167.44 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 130 | 88 | $166.17 |
| J1644 | Injection, heparin sodium, per 1000 units | 85 | 51 | $162.91 |
| J2060 | Injection, lorazepam, 2 mg | 224 | 120 | $155.27 |
| 83880 | 43 | 28 | $120.40 | |
| 87081 | 118 | 76 | $113.00 | |
| 96376 | 273 | 156 | $109.32 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 749 | 570 | $96.24 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 102 | 78 | $81.67 |
| 0012A | 61 | 50 | $37.79 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 282 | 237 | $36.00 |
| 87147 | 12 | 12 | $26.32 | |
| 86901 | 154 | 108 | $4.14 | |
| 81025 | 199 | 178 | $1.77 | |
| 84100 | 113 | 77 | $1.48 | |
| 82248 | 96 | 79 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 21 | 12 | $0.00 |
| 80143 | 13 | 12 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 24 | 21 | $0.00 |
| 80179 | 13 | 12 | $0.00 | |
| 87040 | 86 | 36 | $0.00 | |
| 85027 | 56 | 40 | $0.00 | |
| 0011A | 29 | 25 | $0.00 | |
| 87581 | 23 | 20 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 14 | 12 | $0.00 |